Literature DB >> 25944493

Viral infection: New options to fight Ebola.

Cláudio Nunes-Alves.   

Abstract

Entities:  

Year:  2015        PMID: 25944493     DOI: 10.1038/nrmicro3492

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


× No keyword cloud information.
  6 in total

1.  Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

Authors:  Selidji T Agnandji; Angela Huttner; Madeleine E Zinser; Patricia Njuguna; Christine Dahlke; José F Fernandes; Sabine Yerly; Julie-Anne Dayer; Verena Kraehling; Rahel Kasonta; Akim A Adegnika; Marcus Altfeld; Floriane Auderset; Emmanuel B Bache; Nadine Biedenkopf; Saskia Borregaard; Jessica S Brosnahan; Rebekah Burrow; Christophe Combescure; Jules Desmeules; Markus Eickmann; Sarah K Fehling; Axel Finckh; Ana Rita Goncalves; Martin P Grobusch; Jay Hooper; Alen Jambrecina; Anita L Kabwende; Gürkan Kaya; Domtila Kimani; Bertrand Lell; Barbara Lemaître; Ansgar W Lohse; Marguerite Massinga-Loembe; Alain Matthey; Benjamin Mordmüller; Anne Nolting; Caroline Ogwang; Michael Ramharter; Jonas Schmidt-Chanasit; Stefan Schmiedel; Peter Silvera; Felix R Stahl; Henry M Staines; Thomas Strecker; Hans C Stubbe; Benjamin Tsofa; Sherif Zaki; Patricia Fast; Vasee Moorthy; Laurent Kaiser; Sanjeev Krishna; Stephan Becker; Marie-Paule Kieny; Philip Bejon; Peter G Kremsner; Marylyn M Addo; Claire-Anne Siegrist
Journal:  N Engl J Med       Date:  2015-04-01       Impact factor: 91.245

2.  A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.

Authors:  Jason A Regules; John H Beigel; Kristopher M Paolino; Jocelyn Voell; Amy R Castellano; Zonghui Hu; Paula Muñoz; James E Moon; Richard C Ruck; Jason W Bennett; Patrick S Twomey; Ramiro L Gutiérrez; Shon A Remich; Holly R Hack; Meagan L Wisniewski; Matthew D Josleyn; Steven A Kwilas; Nicole Van Deusen; Olivier Tshiani Mbaya; Yan Zhou; Daphne A Stanley; Wang Jing; Kirsten S Smith; Meng Shi; Julie E Ledgerwood; Barney S Graham; Nancy J Sullivan; Linda L Jagodzinski; Sheila A Peel; Judie B Alimonti; Jay W Hooper; Peter M Silvera; Brian K Martin; Thomas P Monath; W Jay Ramsey; Charles J Link; H Clifford Lane; Nelson L Michael; Richard T Davey; Stephen J Thomas
Journal:  N Engl J Med       Date:  2015-04-01       Impact factor: 91.245

3.  Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates.

Authors:  Andrea Marzi; Peter Halfmann; Lindsay Hill-Batorski; Friederike Feldmann; W Lesley Shupert; Gabriele Neumann; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  Science       Date:  2015-03-26       Impact factor: 47.728

4.  Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial.

Authors:  Feng-Cai Zhu; Li-Hua Hou; Jing-Xin Li; Shi-Po Wu; Pei Liu; Gui-Rong Zhang; Yue-Mei Hu; Fan-Yue Meng; Jun-Jie Xu; Rong Tang; Jin-Long Zhang; Wen-Juan Wang; Lei Duan; Kai Chu; Qi Liang; Jia-Lei Hu; Li Luo; Tao Zhu; Jun-Zhi Wang; Wei Chen
Journal:  Lancet       Date:  2015-03-25       Impact factor: 79.321

5.  Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates.

Authors:  Emily P Thi; Chad E Mire; Amy C H Lee; Joan B Geisbert; Joy Z Zhou; Krystle N Agans; Nicholas M Snead; Daniel J Deer; Trisha R Barnard; Karla A Fenton; Ian MacLachlan; Thomas W Geisbert
Journal:  Nature       Date:  2015-04-22       Impact factor: 49.962

6.  Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.

Authors:  Chad E Mire; Demetrius Matassov; Joan B Geisbert; Theresa E Latham; Krystle N Agans; Rong Xu; Ayuko Ota-Setlik; Michael A Egan; Karla A Fenton; David K Clarke; John H Eldridge; Thomas W Geisbert
Journal:  Nature       Date:  2015-04-08       Impact factor: 49.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.